| Literature DB >> 32380785 |
Edyta B Hendiger1,2, Marcin Padzik2, Ines Sifaoui1, María Reyes-Batlle1, Atteneri López-Arencibia1, Aitor Rizo-Liendo1, Carlos J Bethencourt-Estrella1, Desirée San Nicolás-Hernández1, Olfa Chiboub1,3, Rubén L Rodríguez-Expósito1, Marta Grodzik4, Anna Pietruczuk-Padzik5, Karolina Stępień5, Gabriela Olędzka2, Lidia Chomicz2, José E Piñero1, Jacob Lorenzo-Morales1.
Abstract
Free living, cosmopolitan amoebae from Acanthamoeba genus present a serious risk to human health. As facultative human parasites, these amoebae may cause Acanthamoeba keratitis (AK). Acanthamoeba keratitis is a severe, vision-threatening corneal infection with non-specific symptoms. The number of reported AK cases worldwide has been increasing every year. Moreover, 90% of Acanthamoeba keratitis cases are related to contact lens use. Wearing and storage contact lenses not in accordance with the physicians and manufacturers recommendations are the primary key risk factors of this disease. Amoebae can easily adhere to the contact lens surface and transmit to the corneal epithelium. Preventing amoebae adhesion to the contact lens surface could significantly decrease the number of AK infections. Until now, the effective therapy against AK is still under development. Currently proposed therapies are mainly limited to the chlorhexidine digluconate combined with propamidine isethionate or hexamidine applications, which are insufficient and very toxic to the eye. Due to lack of effective treatment, looking for new potential preventive agents is crucial to decrease the number of Acanthamoeba keratitis infections, especially among contact lens users. Nanoparticles have been already included in several novel therapies against bacteria, viruses, fungi, and protist. However, their anti-amoebic potential has not been fully tested yet. The aim of this study was to assess silver nanoparticles (AgNPs) and platinum nanoparticles (PtNPs) anti-amoebic activity and influence on the amoebae adhesion to the surface of four different groups of contact lenses-classified according to the Food and Drugs Administration (FDA) guidelines. The obtained results show that both tested nanoparticles were effective against Acanthamoeba trophozoites and decreased the amoebae adhesion to the contact lens surface. AgNPs showed better anti-amoebic activity to cytotoxicity dependence and reduced amoebae adhesion in a wider spectrum of the tested contact lenses. Our studies also confirmed that ionization next to hydration of the contact lens material is a crucial parameter influencing the Acanthamoeba adhesion to the contact lens surface. In conclusion, silver nanoparticles might be considered as a novel preventive agent against Acanthamoeba keratitis infection.Entities:
Keywords: Acanthamoeba; adhesion; contact lenses; keratitis; nanoparticles
Year: 2020 PMID: 32380785 PMCID: PMC7281428 DOI: 10.3390/pathogens9050350
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1TEM images of silver nanoparticles (AgNPs) distribution and diameter.
Figure 2TEM images of platinum nanoparticles (PtNPs) distribution and diameter.
Figure 3The anti-amoebic activity of the tested nanoparticles after 96 h of incubation: (A) control; (B) AgNPs 50 ppm; and (C) PtNPs 50 ppm.
Figure 4Comparison of anti-amoebic activity (IC) and cytotoxicity (CC) of AgNPs.
Figure 5Comparison of anti-amoebic activity (IC) and cytotoxicity (CC) of PtNPs.
Figure 6The Acanthamoeba trophozoites adhesion to the contact lenses surface of four FDA groups after 90 min of incubation: (A) FDA 1; (B) FDA 2; (C) FDA 3; and (D) FDA 4.
The detailed Acanthamoeba adhesion observation data.
| FDA 1 | FDA 2 | FDA 3 | FDA 4 | |
|---|---|---|---|---|
| adhesion arrangement | not regular | not regular, grouped | monolayer | monolayer |
| adhesion strength | mild | mild | strong | strong |
| detachment of cells after washing | moderate | strong | mild | mild |
Figure 7Visualized adhesion reduction on FDA 3 contact lenses, treated with different concentrations of AgNPs: (A) control; (B) 6,25 ppm; (C) 12,5 ppm; (D) 25 ppm; (E) 50 ppm; and (F) 60 ppm.
Adhesion reduction (%) results after treatment with different concentrations of nanoparticles in the FDA 3 contact lenses.
| NPs Concentration (ppm) | AgNPs | PtNPs |
|---|---|---|
| 60 | 55.46 | 43.51 |
| 50 | 42.92 | 12.98 |
| 25 | 48.38 | 2.21 |
| 12.5 | 10.18 | 0 |
| 6.25 | 0 | 0 |
Characterization of the FDA types of hydrogel contact lenses used in the study.
| Polymer | FDA Group | Water Content | Ionic | Silicon Content | Manufacturer |
|---|---|---|---|---|---|
| Senofilcon A | 1 | 38% | no | yes | ACUVUE oasys |
| Hilafilcon B | 2 | 59% | no | no | Baush&Lomb SofLens |
| Balafilcon A | 3 | 36% | yes | yes | Baush&Lomb PureVision |
| Methafilcon A | 4 | 55% | yes | no | FitView |